BioSpace News Archive

Trevena, Inc., a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system disorders, announced that members of Management will participate in three upcoming conferences.

Axsome Therapeutics, Inc. today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Officer, will participate in a fireside chat at the Bank of America Securities 2023 Healthcare Conference being held in Las Vegas, Nevada on Thursday, May 11, 2023, at 12:20 p.m. Eastern Time / 9:20 a.m. Pacific Time.

Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2023 financial results.

GlycoMimetics, Inc. today reported its financial results and highlights for the first quarter ended March 31, 2023.

Newron to Present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS).

Recora, the leader in virtual cardiac recovery, and Nevada Heart and Vascular Center, the largest cardiovascular provider in Southern Nevada, announced a partnership to launch virtual cardiac rehabilitation for heart disease patients.

NeoGenomics, Inc.today announced the company will be participating in the upcoming BofA Securities 2023 Healthcare Conference in Las Vegas, Nevada.

Marinus Pharmaceuticals, Inc. today announced that management will present and participate during the following conferences in May.

Affinia Therapeutics today announced that new preclinical data will be presented in an oral and poster sessions at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, being held May 16-20, 2023 in Los Angeles, CA.

Small Pharma Inc. is pleased to announce that Dr. Carol Routledge, Chief Medical and Scientific Officer, will deliver a poster presentation at the 34th CINP World Congress of Neuropsychopharmacology in Montreal, Canada which is taking place on May 7-10, 2023.